Brown, Lisle/Cummings’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Brown, Lisle/Cummings's AMGN Position: Q1 2026 in Review
Brown, Lisle/Cummings increased its Amgen (AMGN) stake by 0.45% in Q1 2026, buying an estimated $38.1K and bringing the position to 24,041 shares worth $8.46M. The position accounts for 2.11% of the portfolio, ranked #8.
Brown, Lisle/Cummings first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Brown, Lisle/Cummings held 24,041 shares of Amgen worth $8.46M as of Q1 2026.
- Brown, Lisle/Cummings bought 107 Amgen shares in Q1 2026, an estimated $38.1K.
- Amgen made up 2.11% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #8 holding.
- Brown, Lisle/Cummings first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.